ALKERMES | ALKS - Devedores Comerciais

Preço das Ações
37.48
Mudança Diária
-0.88 -2.29%
Mensal
11.00%
Anual
19.29%
Q2 Previsão
36.35




Devedores Comerciais Alterar Data
AbbVie USD 12.59B 180M 2025-12
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
ALKERMES USD 407.63M 73.6M 2026-03
Amgen USD 9.14B 432M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Malin Corporation EUR 500K 300K 2024-12
Merck USD 11.78B 345M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Otsuka Holdings JPY 537.37B 32.95B 2026-03
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 16.17B 332M 2026-03
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03